With the Rise in Focus on Value-based Care, Technology Convergence will Drive Care Delivery Innovation Globally, 2019 will be a year of value-based care, as ‘outcome-based care’ focus will globalize.This will trigger the maturation of risk-sharing in solution contracting between providers and drug/device OEMs, driving business value for providers.
Access to affordable and quality care will be key political agendas for the upcoming 2019 elections in emerging markets such as Asia, Africa, and Central and Eastern European countries. Future drugs and devices R&D investments will be more targeted to meet the unique needs of emerging markets.
As the lines between retail, IT, and healthcare markets continue to blur, digital marketplace providers such as Amazon will dominate the home health space, but will find it difficult to compete in the traditional B2B hospital/providers space dominated by established participants.Non-traditional participants such as Amazon, Ali Health, Microsoft, and IBM with digital technologies will provide the required impetus to public health systems to ensure accessibility and affordability of care.
During 2019, digital health will start to come of age—favorable reimbursement policies toward clinically relevant digital health applications will expand care delivery models beyond physical medicine to include behavioral health, digital wellness therapies, dentistry, nutrition, and prescription management.
Research Scope In this research deliverable, Frost & Sullivan provides bold perspectives and predictions for the global healthcare market in 2019.The sectors covered include pharmaceuticals and biotech, in-vitro diagnostics, medical technologies, medical imaging, and healthcare IT.
The analysis captures sectoral and regional trends and provides predictions for the upcoming year. The study provides guidance on where to find the greatest opportunities for expansion.
Key Features Predictions for the global healthcare market in 2019 include:
• Value-based care progressing globally • Artificial Intelligence (AI) exploding across the healthcare and life sciences ecosystem post flagship level use cases yielding positive results • Digital health coming of age with increased focus on individual care • Asia becoming the new local innovation hub for global drug and device OEMs • Healthcare data analytics focus shifting from Big Data to meaningful small data by hospital specialty • Healthcare to be a dominant vertical in voice applications as HIPAA-compliant voice and chatbot applications for healthcare gain prominence • Blockchain move from hype to reality with initial commercial implementations across focused B2B enterprise blockchain applications • Innovative private insurance models shaking up the healthcare payer market
Key Issues Addressed • What are the top predictions for healthcare markets in 2018? • What are the market revenues and growth rates expected for the global healthcare market? • What are the key projections and growth opportunities for major healthcare market segments? • What are the major macro and micro-regional/country-level trends specific to the healthcare market? • What are the key technologies and growth opportunities to watch out for during 2018?
Author:Kamaljit Behara
Our reports have been used by over 10K customers, including:
The global liquid biopsy market is expected to reach nearly US$ 6.5 Billion by 2026. Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures. The abilities of liquid biopsy like, easy and minimal invasiveness, early cancer diagnosis & detection, characterization...
In the report the dPCR and qPCR market, the market is expected to reach US$ 6,371.6 Mn in 2025 from US$ 3,255.5 in 2017. The market is estimated to grow with a CAGR of 9.1% from 2017-2025. The dPCR and qPCR market is driven by the driving factor such as increasing incidence of genetic diseases, growth in investments & funds for dPCR and...
The rising adoption of third-party quality controls is expected to drive the overall growth of the molecular quality controls market. The molecular quality controls market is expected to grow from USD 132 million in 2018 to USD 237 million by 2024, at a CAGR of 10.2% during the forecast period. The molecular quality controls...
The forensic equipment and supplies market is projected to grow at a CAGR of 7.7% during the forecast period The global forensic equipment and supplies market is projected to reach USD 8.7 billion by 2024 from USD 6.0 billion in 2019, at a CAGR of 7.7%. The growth of this market is majorly driven by factors such as the...
The APAC & MEA laboratory equipment market is projected to reach values of approximately $6 billion by 2024, growing at a CAGR of around 6% during 2018-2024. The significant research done across food, chemicals, industrial, and environmental industries will drive the need for dynamic scientific lab supplies across the market. The vendors...
The global laboratory information management systems market is expected to reach US$ 2,168.1 Mn in 2025 from US$ 481.8 Mn in 2017. The market is estimated to grow with a CAGR of 20.9% from 2018-2025. Driving factors such as rising adoption of automation in laboratories and technological advancements in laboratory information management...
WinterGreen Research announces the following study Alcohol Testers and Drug Testers Market Shares, Strategies, and Forecasts, Worldwide, 2019-2025. Alcohol abuse and drug abuse represent a significant danger to society. Most users are benign but the risk to society from drunk driving and workplace accidents demand that some controls be put...
The lab balances and scales market is projected to grow at a CAGR of 3.7% during the forecast period The global lab balances and scales market is projected to reach USD 1.6 billion by 2023 from USD 1.3 billion in 2018, at a CAGR of 3.7%. The growth of this market is largely driven by factors such as increasingly stringent...
In the report the NGS based RNA seq market, the market is expected to reach US$ 7,984.90 Mn in 2027 from US$ 1,414.59 in 2018. The market is estimated to grow with a CAGR of 19.3% from 2018-2027. The NGS based RNA seq market is driven by the driving factor such as reduced cost of genome sequencing, advancements in sequencing technology...
2019-2023 Germany Diagnostics Market This new report provides an overview of the German diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: - Blood...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.